Replies to post #240301 on Biotech Values

[DewDiligence]

YMTX 60% workforce reduction:

https://finance.yahoo.com/news/yumanity-therapeutics-exploring-strategic-alternatives-133000526.html

They’ve belatedly acknowledged that the “positive” data in PD weren’t (#msg-166711510).